Titan Biotech Share Price

434.105.65 (1.31%)

BSE

Closed
As On:
As On: 19 Jun, 2026, 03:51 PM IST

Sector: Chemicals
Industry: Chemicals - Others

STOCK SCORE

Unlock Scores

1D
1W
1M
3M
6M
1Y
5Y

Loading...

Try ETMarkets GPTNEW

Open	-
High	-
Low	-
Prev Close	-
Volume	-
VWAP(₹)	-

Share Price	Value
Today/Current/Last	-434.10
Previous Day	-428.45

Titan Biotech Share Recommendations

No Recommendations details available for this stock.
Check out other stock recos.

News & Analysis

View all Titan Biotech Share News & Announcements

Share Analysis

EARNINGS

FUNDAMENTAL

RELATIVE VALUATION

RISK

PRICE MOMENTUM

Unlock Stock Score, Analyst' Ratings & Recommendations

Score on 10-point scale
Ratings by analysts
Stock performance

JOIN ET PRIME

Financials

Income (P&L)

	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024
Total Income	57.76	55.68	47.22	36.55	39.87
Total Income Growth (%)	3.74	17.92	29.19	-8.32	-0.86
Total Expenses	46.94	46.24	38.91	31.44	34.61
Total Expenses Growth (%)	1.53	18.83	23.75	-9.16	4.17
EBIT	10.82	9.44	8.31	5.11	5.25
EBIT Growth (%)	14.58	13.67	62.66	-2.78	-24.76
Profit after Tax (PAT)	8.53	7.76	6.86	4.05	4.39
PAT Growth (%)	9.84	13.14	69.59	-7.82	-34.43
EBIT Margin (%)	18.73	16.96	17.59	13.97	13.18
Net Profit Margin (%)	14.76	13.95	14.53	11.07	11.01
Basic EPS (₹)	10.32	9.40	8.30	4.90	5.31

	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024
Total Income	57.76	55.68	47.22	36.55	39.87
Total Income Growth (%)	3.74	17.92	29.19	-8.32	-0.86
Total Expenses	46.94	46.24	38.91	31.44	34.61
Total Expenses Growth (%)	1.53	18.83	23.75	-9.16	4.17
EBIT	10.82	9.44	8.31	5.11	5.25
EBIT Growth (%)	14.58	13.67	62.66	-2.78	-24.76
Profit after Tax (PAT)	7.87	6.86	6.16	3.77	3.80
PAT Growth (%)	14.66	11.39	63.59	-0.94	-24.02
EBIT Margin (%)	18.73	16.96	17.59	13.97	13.18
Net Profit Margin (%)	13.62	12.33	13.05	10.30	9.54
Basic EPS (₹)	9.52	8.30	7.46	4.56	4.60

	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Revenue	160.36	165.82	145.94	153.83	143.03
Total Revenue Growth (%)	-3.29	13.62	-5.13	7.56	79.03
Total Expenses	136.00	134.29	117.83	115.63	100.00
Total Expenses Growth (%)	1.27	13.97	1.90	15.64	42.65
Profit after Tax (PAT)	21.53	24.85	24.84	28.74	30.34
PAT Growth (%)	-13.36	0.04	-13.57	-5.25	329.33
Operating Profit Margin (%)	16.08	19.92	20.04	25.83	31.42
Net Profit Margin (%)	13.76	15.14	17.25	18.80	21.32
Basic EPS (₹)	26.06	30.07	25.44	30.66	36.71

	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Revenue	160.36	165.82	145.94	124.49	123.12
Total Revenue Growth (%)	-3.29	13.62	17.23	1.11	76.17
Total Expenses	136.00	134.29	117.83	95.52	84.03
Total Expenses Growth (%)	1.27	13.97	23.35	13.67	34.98
Profit after Tax (PAT)	18.27	23.66	21.02	21.68	28.77
PAT Growth (%)	-22.79	12.55	-3.04	-24.64	363.97
Operating Profit Margin (%)	16.08	19.92	20.04	24.08	32.95
Net Profit Margin (%)	11.67	14.42	14.60	17.55	23.49
Basic EPS (₹)	22.11	28.64	25.44	26.24	34.82

All figures in Rs Cr, unless mentioned otherwise

Insights

Beating 3 Yr Revenue CAGR
Company's annual revenue growth of 31.95% outperformed its 3 year CAGR of 13.04%. (Source: Consolidated Financials)
Employee & Interest Expense
Company has spent less than 1% of its operating revenues towards interest expenses and 15.7% towards employee cost in the year ending Mar 31, 2026. (Source: Consolidated Financials)

View Details

Balance Sheet

Annual	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Assets	174.71	156.58	134.52	143.40	100.72
Total Assets Growth (%)	11.58	16.40	-6.20	42.38	32.45
Total Liabilities	21.30	23.13	24.60	37.99	28.24
Total Liabilities Growth (%)	-7.89	-6.00	-35.23	34.51	-18.13
Total Equity	153.40	133.45	109.91	105.41	72.48
Total Equity Growth (%)	14.95	21.42	4.27	45.44	74.45
Current Ratio (x)	4.46	3.77	3.36	3.62	3.10
Total Debt to Equity (x)	0.01	0.05	0.06	0.16	0.19
Contingent Liabilities	7.78	12.90	1.13	3.20	0.38

Annual	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Assets	166.44	151.57	130.70	107.56	86.17
Total Assets Growth (%)	9.81	15.97	21.51	24.82	32.16
Total Liabilities	21.30	23.13	24.60	21.32	20.35
Total Liabilities Growth (%)	-7.91	-5.98	15.38	4.77	-25.70
Total Equity	145.13	128.44	106.09	86.24	65.82
Total Equity Growth (%)	12.99	21.07	23.02	31.02	74.08
Current Ratio (x)	4.46	3.77	3.36	3.85	3.49
Total Debt to Equity (x)	0.01	0.06	0.07	0.07	0.11
Contingent Liabilities	7.78	12.90	1.13	3.20	0.77

All figures in Rs Cr, unless mentioned otherwise

View Details

Cash Flows

Annual	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Net Cash flow from Operating Activities	20.12	21.15	21.18	22.86	19.24
Net Cash used in Investing Activities	-9.87	-20.30	-20.73	-18.78	-8.08
Net Cash flow from Financing Activities	-7.96	-2.87	-2.40	6.08	-7.54
Net Cash Flow	2.29	-2.02	-1.95	10.16	3.62
Closing Cash & Cash Equivalent	5.13	2.84	4.86	15.61	5.45
Closing Cash & Cash Equivalent Growth (%)	80.55	-41.61	-68.84	186.33	197.41
Total Debt/ CFO (x)	0.10	0.34	0.33	0.69	0.68

Annual	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Net Cash flow from Operating Activities	20.12	21.15	21.18	21.95	17.75
Net Cash used in Investing Activities	-9.87	-20.30	-20.73	-16.44	-4.33
Net Cash flow from Financing Activities	-7.96	-2.87	-2.40	-4.01	-9.81
Net Cash Flow	2.29	-2.02	-1.95	1.51	3.61
Closing Cash & Cash Equivalent	5.13	2.84	4.86	6.81	5.31
Closing Cash & Cash Equivalent Growth (%)	80.55	-41.61	-28.62	28.36	212.09
Total Debt/ CFO (x)	0.10	0.34	0.33	0.26	0.42

All figures in Rs Cr, unless mentioned otherwise

Insights

Increase in Cash from Investing
Company has used Rs 34.41 cr for investing activities which is an YoY increase of 248.52%. (Source: Consolidated Financials)

View Details

Ratios

Annual	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Return on Equity (%)	14.03	18.62	22.60	29.13	44.11
Return on Capital Employed (%)	16.03	23.78	25.28	33.41	54.77
Return on Assets (%)	12.32	15.87	18.46	20.04	30.11
Interest Coverage Ratio (x)	36.59	30.79	42.18	32.76	26.80
Asset Turnover Ratio (x)	0.94	1.13	1.04	1.19	141.22
Price to Earnings (x)	16.18	17.57	6.55	7.54	5.06
Price to Book (x)	2.27	3.27	1.48	2.19	2.23
EV/EBITDA (x)	11.76	12.23	5.24	5.32	3.51
EBITDA Margin (%)	18.75	21.95	21.84	27.49	32.98

Annual	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Return on Equity (%)	12.58	18.42	19.81	25.14	43.71
Return on Capital Employed (%)	16.92	24.68	26.15	32.64	56.20
Return on Assets (%)	10.97	15.61	16.08	20.15	33.39
Interest Coverage Ratio (x)	36.59	30.79	42.18	40.98	31.65
Asset Turnover Ratio (x)	0.98	1.16	1.21	1.28	142.11
Price to Earnings (x)	19.08	18.45	7.74	9.99	5.33
Price to Book (x)	2.40	3.40	1.53	2.51	2.33
EV/EBITDA (x)	11.77	12.23	5.24	6.71	3.66
EBITDA Margin (%)	18.75	21.95	21.84	25.99	34.67

Found Financials useful?

5 Days	14 Days	28 Days
-	-	-

Peer Comparison

Ratio Performance

NAME	P/E (x)	P/B (x)	ROE %	ROCE %	ROA %	Rev CAGR [3Yr]	OPM	NPM	Basic EPS	Current Ratio	Total Debt/ Equity (x)	Total Debt/ CFO (x)
Titan Biotech	60.02	9.88	16.46	20.80	13.97	13.04	18.95	13.31	7.23	3.28	0.02	0.12
Tatva Chintan Pharma Chem	66.51	3.58	5.37	7.57	4.18	5.80	11.83	8.31	17.98	1.64	0.15	3.82
Camlin Fine Sc	98.04	2.71	2.65	4.79	1.18	1.25	3.75	1.26	1.46	1.27	0.64	8.14
Stallion India Fluorochemicals Ltd.	49.87	3.21	6.44	8.78	5.94	24.03	13.90	10.17	5.34	11.85	0.05	0.86
Thirumalai Chem	-12.00	1.29	-10.73	-3.04	-3.54	-6.67	-6.03	-9.67	-14.91	0.61	1.34	-16.01
Add More

Annual Ratios (%)

Choose from Peers

S H Kelkar & Co.
Gulshan Polyols
Meghmani Organics
Shree Pushkar Chem
Paushak Ltd

Choose from Stocks

Stock Performance

CHART
TABLE

1D
1W
1M
3M
6M
1Y
5Y

Choose from Peers
Choose from Stocks

NAME	1D	1W	1M	3M	1Y	3Y	5Y
Titan Biotech Stock Performance	1.31	-6.00	-7.61	45.79	375.41	810.25	608.85
Tatva Chintan Pharma Chem Stock Performance	-0.12	-5.35	-6.44	-0.03	23.70	-28.04	0.00
Camlin Fine Sc Stock Performance	2.65	14.22	35.98	-0.98	-26.87	-18.21	-13.47
Stallion India Fluorochemicals Ltd. Stock Performance	-1.46	36.88	16.09	38.70	145.15	0.00	0.00
Thirumalai Chem Stock Performance	-3.46	-20.65	-16.22	-18.00	-32.94	-7.58	36.95
Add More

Category	No. of Shares	Percentage
Promoters	2,30,47,520	55.78 %
Pledge	0	0.00 %
DII	11,950	0.03 %
Others	1,82,59,030	44.19 %

Category	Mar 2026	Dec 2025	Sep 2025	Jun 2025
Promoters	55.78	55.78	55.78	55.88
Pledge	0.00	0.00	0.00	0.00
FII	0.00	0.00	0.00	0.00
DII	0.03	0.03	0.03	0.03
Mutual Funds	0.00	0.00	0.00	0.00
Others	44.19	44.19	44.19	44.08

Mutual Funds Ownership

No Data Available

Corporate Actions

Recent
Board Meeting
Audited Results & Final Dividend
May 20, 2026
Board Meeting
Quarterly Results
Feb 03, 2026
General Meeting
-
Dec 01, 2025

Board Meetings

Announced on	Meeting on
May 20, 2026	May 30, 2026
Audited Results & Final Dividend
Feb 03, 2026	Feb 12, 2026
Quarterly Results
Nov 25, 2025	Nov 29, 2025
Stock Split
Nov 04, 2025	Nov 11, 2025
Quarterly Results
Aug 01, 2025	Aug 13, 2025
Quarterly Results

Dividends
Announced on Ex-Date Dividend%
May 30, 2025 Sep 19, 2025 20%
May 29, 2024 Sep 23, 2024 20%
Sep 06, 2023 Sep 22, 2023 18%
Jun 01, 2022 Sep 22, 2022 15%
Jul 01, 2021 Sep 16, 2021 15%
Bonus
No Data Available
Splits
Announced on Ex-Date
Nov 29, 2025 Feb 20, 2026
Split: Old FV10.0| New FV:2.0
Rights
No Data Available

Announced on	Ex-Date	Dividend%
May 30, 2025	Sep 19, 2025	20%
May 29, 2024	Sep 23, 2024	20%
Sep 06, 2023	Sep 22, 2023	18%
Jun 01, 2022	Sep 22, 2022	15%
Jul 01, 2021	Sep 16, 2021	15%

Announced on	Ex-Date
Nov 29, 2025	Feb 20, 2026
Split: Old FV10.0\| New FV:2.0

AGM/EGM Meetings

Announced on	Meeting on
Dec 01, 2025	Jan 01, 2026
-
Aug 13, 2025	Sep 26, 2025
-
Sep 20, 2024	Sep 30, 2024
Rs.2.0000 per share(20%)Dividend & A.G.M.
Sep 06, 2023	Sep 29, 2023
Rs.1.8000 per share(18%)Final Dividend & A.G.M.
Aug 24, 2020	Sep 25, 2020
Book closure from Sep 19, 2020 to Sep 25, 2020

About Titan Biotech

Titan Biotech Ltd., incorporated in the year 1992, is a Small Cap company (having a market cap of Rs 1,793.64 Crore) operating in Chemicals sector.

Titan Biotech Ltd. key Products/Revenue Segments include Biological Product for the year ending 31-Mar-2025.

For the quarter ended 31-03-2026, the company has reported a Consolidated Total Income of Rs 50.94 Crore, down 11.81 % from last quarter Total Income of Rs 57.76 Crore and up 39.37 % from last year same quarter Total Income of Rs 36.55 Crore. Company has reported net profit after tax of Rs 6.56 Crore in latest quarter.

The company’s top management includes Mr.Rohit Jain, Mr.Naresh Kumar Singla, Mr.Suresh Chand Singla, Mr.Raja Singla, Mr.Shivom Singla, Mr.Udit Singla, Mr.Abhishek Agarwal, Mr.Brijesh Kumar Singh, Mr.Dhairya Madan, Mrs.Manju Singla, Ms.Supriya Singla, Mr.Debendra Kumar Sabat, Mr.Prem Shankar Gupta, Mr.Charanjit Singh. Company has Sunita Agrawal & Co. as its auditors. As on 31-03-2026, the company has a total of 4.13 Crore shares outstanding.

Titan Biotech Share Price Today is Rs. 434.10. On previous day, the Titan Biotech Share Price (NSE) closed at Rs. 428.45, featuring among the most traded securities on the National Stock Exchange.

Shareholdings:
As of 31st Mar, 2026, the promoter held 55.78% of the stake in Titan Biotech shares, out of which 0.0% was pledged. On the same date, foreign institutional investors' (FII) holdings of Titan Biotech stocks was 0.0% as compared to 0.0% in Dec 2025 with null of 0.0%. The domestic institutional investors (DII) holdings on 31st Mar, 2026 was 0.03% as compared to 0.03% in Dec 2025 with decrease of 0.0%. Out of the total DII holdings in Titan Biotech shares 0.0% was held by mutual funds. The rest including public held is 0.0%. Titan Biotech stock price is reflected on both the exchanges - BSE and NSE.

Dividend, Bonus & Split Information:
Titan Biotech Dividend: Ever since 1992, Titan Biotech dividends has been paid out around 14 times. As on 19 Jun, 2026, 03:51 PM IST, The overall dividend yield for Titan Biotech stands at 0.0%. The last dividend paid was on September 19, 2025 (Rs. 2.0). The Earnings Per Share (EPS) for quarter ending 31st Mar 2026 is Rs. 7.23.

Titan Biotech Bonus: The most recent bonus issue had been in year null around 0 years ago at 0 : 0 ratio. The first bonus issue was announced in null.

Stock Forecast:
After showing 50.94 Cr. of sales and 11.81% of quarterly net loss, there have been multiple ups and downs in the Titan Biotech stock prices in the past few weeks. For example, Titan Biotech stock price on 12th of June 2026 was around Rs. 444.75. Titan Biotech share price now stands at an average of Rs. 434.10. Judging by last week's performance, stock is in down trend.

Titan Biotech has a median target price of Rs. 0.0 in 12 months by 0 analysts. They have provided a high estimate of Rs. 0.0 and low estimate of Rs. 0.0 for Titan Biotech share.

Historical Prices and Performance:
Titan Biotech, incorporated in 1992 is a Small Cap company (with a market cap of Rs. 1793.64) operating in Chemicals sector.
The Return of Equity (ROE) in last five financial years given by Titan Biotech stock was 16.46%, 14.03%, 18.62%, 22.6% and 29.13% respectively.
The Titan Biotech share gave a 3 year return of 735.61% as compared to Nifty 50 which gave a return of 28.03%.
Titan Biotech announced 20.0% final dividend on September 19, 2025.

Key Metrics:
PE Ratio of Titan Biotech is 59.59
Prices/Sales Ratio of Titan Biotech is 9.17
Price/Book Ratio of Titan Biotech is 9.81

Peer Insights:
Peers are businesses with comparable activities, buisness objectives and affiliation with a particular industry area. The PE ratio and PB Ratio of the company are among its competitors stand at 59.59 and 9.81 respectively.

Leadership of Titan Biotech :
Charanjit Singh is Co. Secretary & Compl. Officer
Prem Shankar Gupta is Chief Financial Officer
Rohit Jain is Chairman & Ind.Director
Naresh Kumar Singla is Managing Director
Suresh Chand Singla is Managing Director
Raja Singla is Whole Time Director
Shivom Singla is Whole Time Director
Udit Singla is Whole Time Director
Manju Singla is Director
Supriya Singla is Director
Abhishek Agarwal is Independent Director
Brijesh Kumar Singh is Independent Director
Dhairya Madan is Independent Director
Debendra Kumar Sabat is Addnl.Independent Director

Industry

Chemicals - Others

Key Indices Listed On

-

Address

A - 902 A, RIICO Industrial Area,Phase - III,Bhiwadi, Rajasthan - 301019

Contact

cs@titanbiotechltd.com

http://www.titanbiotechltd.com

PE Ratio(x)	60.02
EPS - TTM(₹)	7.23
MCap(₹ Cr.)	1,793.64
MCap Rank	50
PB Ratio(x)	9.81
Div Yield(%)	-
Face Value(₹)	2.00
52W High(₹)	555.65
52W Low(₹)	74.73
MCap/Sales	9.17
Beta(1 Month)	-0.20
BV/Share(₹)	43.94

1 Day	1.31%
1 Month	3.58%
3 Months	10.99%
1 Year	446.86%
3 Years	735.61%
5 Years	485.51%

R1	-	Pivot -	S1	-
R2	-		S2	-
R3	-		S3	-

Titan Biotech Share Price

Key Metrics